Multi-omics in Colon Cancer and Role of the Microbiome
Dr. Souhaila Al Khodor from Sidra Medicine, Qatar will join the Targeting Microbiota 2023 congress to talk about: "Multi-omics in Colon Cancer and Role of the Microbiome".
This study consisted of 348 treatment-naïve patients with colon cancer that were profiled using various omics including 16S rRNA gene sequencing and complemented with tumor whole-genome sequencing for further microbiome analysis. Dr. Al Khodor and her team characterized the immune-microbiota interactions in those patients and identified microbial signatures predictive of overall survival.
They identified a microbiome signature, driven by Ruminococcus bromii, that was associated with a favorable outcome. This study is a step forward toward implementing microbiota-targeting approaches, such as dietary intervention in the adjuvant or neoadjuvant setting.
Join Targeting Microbiota 2023 to learn more about Dr. Khodor's talk.
You can share your related work by submitting your abstract.
Targeting Microbiota 2023 Congress
October 17-19, 2023 - Venice
Linkedin | Facebook | Website
